2.090USDMkt Cap: 196.26M $P/E: —1d ago
Innate Pharma S.A. operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which …
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap196.26M $
Enterprise Value183.35M $
Revenue (TTM)9.01M $
Gross Profit-34.62M $
Net Income (TTM)-49.18M $
Revenue/Share0.1010 USD
Last Price2.090 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees164
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINFR0010331421
Valuation
P/E (Trailing)—
P/E (Forward)-3.31
PEG—
EV/EBITDA-3.44
EV/Revenue20.36
P/S21.79
P/B-7.78
EPS (TTM)-0.64
EPS (Forward)-0.63
52W Range
2.05036% of range2.160
52W High2.160 USD
52W Low2.050 USD
Profitability
Gross Margin0.00%
Oper. Margin-689.55%
EBITDA Margin0.00%
Profit Margin-1764.51%
ROE226.58%
ROA-78.41%
Growth
Revenue Growth-46.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-32.56M $
CapEx (TTM)2.35M $
FCF Margin-378.39%
FCF Yield-17.36%
Net Debt-11.74M $
Net Debt/EBITDA0.22
Balance Sheet
Debt/Equity-1.04
Current Ratio1.27
Quick Ratio1.14
Book Value/Sh-0.2686 USD
Cash/Share0.3660 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)7.000 USD
Upside (mean)+234.9%
Target Range4.000 USD – 9.000 USD
$4.000+234.9% to mean$9.000
# Analysts4
Ownership
Shares Out.93.90M
Float70.57M
Insiders1.40%
Institutions0.38%
Short Interest
Short Ratio22.8d
Short % Float0.16%
Short % Out.0.16%
Shares Short152.43K
Short (prev mo.)179.94K
Technical
SMA 501.862 (+12.3%)
SMA 2001.730 (+20.8%)
Beta0.86
S&P 52W Chg21.00%
Avg Vol (30d)52.43K
Avg Vol (10d)823.93K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—